eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
4/2019
vol. 11
 
Share:
Send email
Share:
abstract:
Case report

Application of tapentadol in elderly patients during systemic treatment – case report

Adriana Maria Stryczyńska-Mirocha
1
,
Martyna Mirocha
2

  1. Katowickie Centrum Onkologii
  2. Collegium Medicum Uniwersytetu Jagiellońskiego
Medycyna Paliatywna 2019; 11(4): 188–192
DOI: https://doi.org/10.5114/pm.2019.93188
Online publish date: 2020/03/04
View full text Get citation
 
PlumX metrics:
The risk of developing cancer increases with age, and pain is one of the most common symptoms associated with cancer. Due to the frequent co-occurrence of other chronic diseases or ailments, the treatment of cancer pain in the elderly can be a challenge for specialists. The need for simultaneous use of many drugs and a high risk of their interaction means that in practice the choice of the appropriate analgesic cannot be accidental. Tapentadol is one of the drugs with a favourable pharmacokinetic profile. By combining in one molecule the μ opioid receptor agonist activity in the central nervous system and inhibiting noradrenaline reuptake in the descending anti-nociceptive system, it is highly effective in the treatment of moderate to severe cancer pain, also with a neuropathic component. Due to the low risk of drug interactions, tapentadol is a safe therapeutic option in patients with multiple diseases.
keywords:

tapentadol, pain treatment, elderly
FEATURED PRODUCTS
BOOKS
• Medycyna Paliatywna
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.